Suppr超能文献

硫化氢及相关含硫物质的前体药物:最新进展

Prodrugs of hydrogen sulfide and related sulfur species: recent development.

作者信息

Yuan Zheng-Nan, Zheng Yue-Qin, Wang Bing-He

机构信息

Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303, USA.

Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30303, USA.

出版信息

Chin J Nat Med. 2020 Apr;18(4):296-307. doi: 10.1016/S1875-5364(20)30037-6.

Abstract

Hydrogen sulfide (HS) is commonly referred to as the third gasotransmitter with firmly established physiological roles. Prodrug approaches have been broadly applied to deliver HS for various applications and mechanistic studies. Since S-persulfidation and glutathionylation are known to be important in cellular signaling by sulfur species, there have been interests in developing donors of persulfide and glutathione persulfide as well. In this review, we discuss the recent development in area of prodrugs for various sulfur species.

摘要

硫化氢(HS)通常被称为具有明确生理作用的第三种气体信号分子。前药方法已被广泛应用于递送HS以用于各种应用和机制研究。由于已知S-过硫化和谷胱甘肽化在硫物种的细胞信号传导中很重要,因此人们也对开发过硫化物和谷胱甘肽过硫化物供体感兴趣。在这篇综述中,我们讨论了各种硫物种前药领域的最新进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验